Rigel Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. ASML
2. USO
3. LAD
4. ROIV
5. DKNG
6. BSX
7. ODFL
8. NVS
9. AHR
10. ALV

Go back to Rigel Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update

Rigel Pharma (RIGL) Tops Q4 EPS by 10c

March 7, 2023 4:02 PM EST

Rigel Pharma (NASDAQ: RIGL) reported Q4 EPS of $0.01, $0.10 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $51.3 million versus the consensus estimate of $36.52 million.

As of December 31, 2022, Rigel had cash, cash equivalents and short-term investments of $58.2 million, compared to $125.0... More